<abstract xmlns="http://www.w3.org/1999/xhtml">

<sec><h3>Background</h3>
<p>Pregnancy is an immuno-compromised state, and pregnant women with COVID-19 are at an increased risk for adverse pregnancy outcomes. Thus, the Center for Disease Control and Prevention (CDC) and the Advisory Committee on Immunization (ACIP) have advocated for COVID-19 vaccination in pregnant women. COVAXIN and COVISHIELD were the vaccines being used in India in the first phase of vaccination, but limited data exist on pregnancy outcomes regarding SARS-CoV-2 vaccines and pregnancy and lactation.</p>
</sec>
<sec><h3>Material and methods</h3>
<p>A retrospective study was conducted which included only women who delivered after 24 weeks gestation. Women with an unknown vaccination status or with past or active COVID-19 infection were excluded. Demographic characteristics, maternal and obstetric outcomes, and fetal and neonatal outcomes were compared between the unvaccinated and vaccinated groups. Statistical analysis was done with Chi-square testing and the Fisher exact test using SPSS-26 software.</p>
</sec>
<sec><h3>Results</h3>
<p>Deliveries before a gestation of 37 weeks were significantly higher in the unvaccinated group compared to the vaccinated group. Rates of vaginal deliveries and preterm deliveries were found to be higher in the unvaccinated population. Women who had taken COVAXIN had a higher rate of adverse events compared to those who had taken COVISHIELD.</p>
</sec>
<sec><h3>Conclusion</h3>
<p>There were no significant differences in adverse obstetric outcomes attributed to vaccine administration between the vaccinated and unvaccinated pregnant women. The beneficial effects of the vaccines in protecting against COVID-19 infection, particularly in pregnancy, outweigh the minor adverse events associated with vaccine administration.</p>
</sec>
</abstract>

Background
Pregnancy is an immuno-compromised state, and pregnant women with COVID-19 are at an increased risk for adverse pregnancy outcomes. Thus, the Center for Disease Control and Prevention (CDC) and the Advisory Committee on Immunization (ACIP) have advocated for COVID-19 vaccination in pregnant women. COVAXIN and COVISHIELD were the vaccines being used in India in the first phase of vaccination, but limited data exist on pregnancy outcomes regarding SARS-CoV-2 vaccines and pregnancy and lactation.

Material and methods
A retrospective study was conducted which included only women who delivered after 24 weeks gestation. Women with an unknown vaccination status or with past or active COVID-19 infection were excluded. Demographic characteristics, maternal and obstetric outcomes, and fetal and neonatal outcomes were compared between the unvaccinated and vaccinated groups. Statistical analysis was done with Chi-square testing and the Fisher exact test using SPSS-26 software.

Results
Deliveries before a gestation of 37 weeks were significantly higher in the unvaccinated group compared to the vaccinated group. Rates of vaginal deliveries and preterm deliveries were found to be higher in the unvaccinated population. Women who had taken COVAXIN had a higher rate of adverse events compared to those who had taken COVISHIELD.

Conclusion
There were no significant differences in adverse obstetric outcomes attributed to vaccine administration between the vaccinated and unvaccinated pregnant women. The beneficial effects of the vaccines in protecting against COVID-19 infection, particularly in pregnancy, outweigh the minor adverse events associated with vaccine administration.

Effects of Covid-19 Vaccination during Pregnancy on the Obstetric and Neonatal Outcomes in a Tertiary Health Care Center

IMS & SUM Hospital, Siksha O Anusandhan (Deemed to be) University

AIPH (Asian Institute of Public Health) University

Journal of Mother and Child

This work is licensed under the Creative Commons Attribution 4.0 International License.

Background
Pregnancy is an immuno-compromised state, and pregnant women with COVID-19 are at an increased risk for adverse pregnancy outcomes. Thus, the Center...

Effects of Covid-19 Vaccination during Pregnancy on the Obstetric and Neonatal Outcomes in a Tertiary Health Care Center

Article Category: Original research

Publié en ligne: 06 juil. 2023

Pages: 72 - 78

Reçu: 03 août 2022

Accepté: 12 janv. 2023

DOI: https://doi.org/10.34763/jmotherandchild.20232701.d-22-00043

Mots clés
COVID-19 vaccines, pregnancy, obstetric outcomes, neonatal outcomes

© 2023 Gargee Suman Tripathy et al., published by Sciendo

This work is licensed under the Creative Commons Attribution 4.0 International License.

Effects of Covid-19 Vaccination during Pregnancy on the Obstetric and Neonatal Outcomes in a Tertiary Health Care Center

Article Category: Original research

Publié en ligne: 06 juil. 2023

Pages: 72 - 78

Reçu: 03 août 2022

Accepté: 12 janv. 2023

DOI: https://doi.org/10.34763/jmotherandchild.20232701.d-22-00043

Mots clésCOVID-19 vaccines, pregnancy, obstetric outcomes, neonatal outcomes

© 2023 Gargee Suman Tripathy et al., published by Sciendo

This work is licensed under the Creative Commons Attribution 4.0 International License.

Mots clés
COVID-19 vaccines, pregnancy, obstetric outcomes, neonatal outcomes